The Financial Conduct Authority (“FCA”) has confirmed that, before 1 September 2026, firms should review and, where necessary, update...
On 21 May 2026, the Medicines and Healthcare products Regulatory Agency (“MHRA”) published its draft regulatory framework for rare...
The UK’s approach to regulating AI chatbots is shifting rapidly in an effort to keep pace with technological change and address the risks...
Competition authorities in the EU and the UK are increasingly scrutinising whether AI‑driven products, data tools and digital ecosystems...
On 7 May 2026, the European Parliament and the Council of the European Union reached a provisional political agreement under the European...
Leadership conduct is now the second-largest category for whistleblowing reports received by the Financial Conduct Authority. With the...
On 15 April 2026, the European Data Protection Board (the "EDPB") adopted draft Guidelines 1/2026 on processing of personal data for...
In this article we address the latest example of why political risk is now a potential issue to be considered when negotiating UK-focused...
In January 2026, the FDA and the European Medicines Agency (the “EMA”) published a set of guiding principles for the use of AI across the...
On 21 April 2026, the Court of Appeal in RTM v Bonne Terre Ltd & Anor ([2026] EWCA Civ 488) clarified the standard for consent under UK...
The FCA and PRA Policy Statements published on 22 April deliver the most significant reform of the Senior Managers & Certification Regime...
The Treasury has published the draft Money Laundering and Terrorist Financing (Amendment) Regulations 2026 (the “2026 Regulations”),...